Photo by lunarts from unsplash
Treatment of patients with advanced non-small cell lung cancer (NSCLC) has undergone dramatic changes in the recent decade. We have now established a treatment model based on precision medicine: detection… Click to show full abstract
Treatment of patients with advanced non-small cell lung cancer (NSCLC) has undergone dramatic changes in the recent decade. We have now established a treatment model based on precision medicine: detection of driver mutations and utilization of targeted agents as well as determination of programmed death-ligand 1 (PD-L1) status and integration of immunotherapy.
Keywords:
moving away;
finally doublet;
lung cancer;
away finally;
lung
Journal Title: Journal of thoracic disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of thoracic disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!